- Home
- KNSA vs INMD Comparison
KNSA vs INMD Comparison
Compare KNSA & INMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KNSA
- INMD
- Stock Information
- Founded
- KNSA 2015
- INMD 2008
- Country
- KNSA United Kingdom
- INMD Israel
- Employees
- KNSA N/A
- INMD N/A
- Industry
- KNSA Biotechnology: Pharmaceutical Preparations
- INMD Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- KNSA Health Care
- INMD Health Care
- Exchange
- KNSA Nasdaq
- INMD Nasdaq
- Market Cap
- KNSA 1.3B
- INMD 1.5B
- IPO Year
- KNSA 2018
- INMD 2019
- Fundamental
- Price
- KNSA $18.73
- INMD $16.96
- Analyst Decision
- KNSA Strong Buy
- INMD Buy
- Analyst Count
- KNSA 5
- INMD 6
- Target Price
- KNSA $36.60
- INMD $22.40
- AVG Volume (30 Days)
- KNSA 469.7K
- INMD 951.8K
- Earning Date
- KNSA 02-26-2025
- INMD 02-04-2025
- Dividend Yield
- KNSA N/A
- INMD N/A
- EPS Growth
- KNSA N/A
- INMD N/A
- EPS
- KNSA N/A
- INMD 1.84
- Revenue
- KNSA $384,098,000.00
- INMD $423,746,000.00
- Revenue This Year
- KNSA $60.05
- INMD N/A
- Revenue Next Year
- KNSA $36.74
- INMD $2.48
- P/E Ratio
- KNSA N/A
- INMD $9.27
- Revenue Growth
- KNSA 54.41
- INMD N/A
- 52 Week Low
- KNSA $16.56
- INMD $14.87
- 52 Week High
- KNSA $28.15
- INMD $26.80
- Technical
- Relative Strength Index (RSI)
- KNSA 38.56
- INMD 48.51
- Support Level
- KNSA $18.27
- INMD $15.43
- Resistance Level
- KNSA $19.05
- INMD $16.80
- Average True Range (ATR)
- KNSA 0.61
- INMD 0.48
- MACD
- KNSA -0.05
- INMD 0.07
- Stochastic Oscillator
- KNSA 34.42
- INMD 75.74
About KNSA Kiniksa Pharmaceuticals Ltd.
Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and mavrilimumab.
About INMD InMode Ltd.
InMode Ltd provides minimally and non-invasive surgical aesthetic and medical treatment solutions in the United States. Its products and solutions address three energy-based treatment categories that include face & body contouring, medical aesthetics, and women's health. InMode has developed products using its technology for plastic surgery, dermatology, gynecology, and ophthalmology. Its product platforms include BodyTite, Optimas, Votiva, Contoura, Triton, EmbraceRF, EvolveX, Evoke, EmpowerRF and Morpheus8. The majority of its revenue comes from the United States.